ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005060:Europe; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D012307:Risk Factors; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents